- In humans, the heart only has very limited capacity to regenerate after injuries.
- t2cure is focussing on bone marrow derived cells (BMCs) for use in cardiac repair.
- t2cure's pipeline is built on clinical studies having been conducted by the founders at Goethe University, Frankfurt.
- t2cure is dedicated to the development of novel progenitor cell-based regenerative therapeutics.
